CalciMedica is trading at $2.18 (-6.12%) after its 1-for-5 reverse stock split became effective after the August 28, 2026 close at 5:00 p.m. ET; the reverse split is the clearest company-specific catalyst for the pre-market decline.
- Split-adjusted trading began August 31, 2026, under the existing symbol.
- Authorized common shares reduced from 500 million to 100 million.